Sponsored by EmVenio
Join us in the atrium for a drinks reception
Archives: Agenda
Reaching underrepresented patients for trials in the current climate
- Why inclusive research is a business and clinical imperative
- How to continue the work in the current climate
- Increasing focus on US enrollment
- Five principles of data driven inclusive research
END OF DAY 1 AND NETWORKING DRINKS
Sponsored by EmVenio
Join us in the atrium for a drinks reception
Patient advocacy and incorporating patient perspectives early on in a small biotech
- Developing relationships with advocacy groups and patient communities from early stages
- How does patient advocacy differ at biotechs vs large pharma?
- Integrating patient insights into your study to ensure patients remain the priority throughout your trial
Managing Drug Development: A Biotech Company Perspective
- Engaging right CROs/CDMOs
- GXP compliance
- Budget, timeline, and conflicts
Making AI approachable
- Move past the hype: Treat AI as a strategic enabler, not a technical hurdle.
- Conversing with data: Use AI to interact with insights rather than just manage information.
- Practical toolkit: Combine everyday assistants with specialized models for rapid document synthesis and cross-referencing.
- Incremental adoption: Integrate AI capabilities gradually without overwhelming learning requirements.
- Outcome: Empower teams to enhance expertise and decision-making with AI.
Speaker Hosted Round Tables
Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry as a whole. Hosted by industry experts and each focused on a single issue, roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others. Each roundtable lasts for 30 minutes, delegates can select up to 2 roundtables.
- Roundtable 1 – Standing out in a sea of sponsors: Practical strategies for small biotechs working with large CROs
Hosted by Rachel Yan, Former Director, Clinical Operations, Allay Therapeutics - Roundtable 2 – Reinforcing the sponsor’s pivotal role in ensuring trial integrity with the latest ICH GCP updates
Hosted by Sharmaine Peterson, Associate Director, Clinical Quality Assurance, Zentalis - Roundtable 3 – The show goes on: Supporting clinical trials during a time of war
Hosted by Jasmine Washington, Head of Clinical Outsourcing and Contract Management, Cytokinetics - Roundtable 4 – Using AI to accelerate data management and improve trial quality
Hosted by Pietro Belligoli, Researcher, Former Roche and Constantin Weberpals, Machine Learning Research Collaborator, Stanford University - Roundtable 5 – Mitigating risk: how to strategically plan and curb risk as a small biotech
Hosted by Chris Adams, Chief Executive Officer, Andarix